Common Contracts
15 similar Transition and Succession Agreement contracts by Mylan Laboratories Inc, Mylan Inc., Mylan N.V.
TRANSITION AND SUCCESSION AGREEMENTTransition and Succession Agreement • May 10th, 2017 • Mylan N.V. • Pharmaceutical preparations • Pennsylvania
THIS TRANSITION AND SUCCESSION AGREEMENT (this “Agreement”) is entered into effective as of the 24th day of March, 2017, by and between Mylan Inc., a Pennsylvania corporation (the “Company”), and Daniel M. Gallagher (the “Executive”).
TRANSITION AND SUCCESSION AGREEMENTTransition and Succession Agreement • August 9th, 2016 • Mylan N.V. • Pharmaceutical preparations • Pennsylvania
THIS TRANSITION AND SUCCESSION AGREEMENT (this “Agreement”) is entered into effective as of the 6th day of June, 2016, by and between Mylan Inc., a Pennsylvania corporation (the “Company”), and Kenneth S. Parks (the “Executive”).
TRANSITION AND SUCCESSION AGREEMENTTransition and Succession Agreement • April 27th, 2012 • Mylan Inc. • Pharmaceutical preparations • Pennsylvania
This Transition and Succession Agreement (this “Agreement”) is dated as of January 10, 2006, by and between Mylan Laboratories Inc., a Pennsylvania corporation (the “Company”), and Harry A. Korman (“Executive”).
TRANSITION AND SUCCESSION AGREEMENTTransition and Succession Agreement • April 27th, 2012 • Mylan Inc. • Pharmaceutical preparations • Pennsylvania
This Transition and Succession Agreement (this “Agreement”) is dated as of February 25, 2008 (the “Commencement Date”) by and between Mylan Inc., a Pennsylvania corporation (the “Company”), and Anthony Mauro (the “Executive”).
TRANSITION AND SUCCESSION AGREEMENTTransition and Succession Agreement • April 30th, 2010 • Mylan Inc. • Pharmaceutical preparations • Pennsylvania
THIS TRANSITION AND SUCCESSION AGREEMENT (this “Agreement”) is entered into effective as of the 1st day of April, 2010 (this “Agreement”), by and between Mylan Inc., a Pennsylvania corporation (the “Company”), and John Sheehan (the “Executive”).
TRANSITION AND SUCCESSION AGREEMENTTransition and Succession Agreement • February 26th, 2010 • Mylan Inc. • Pharmaceutical preparations • Pennsylvania
This Transition and Succession Agreement (this “Agreement”) is dated as of February 28_, 2008 (the “Commencement Date”) by and between Mylan Inc., a Pennsylvania corporation (the “Company”), and Daniel C. Rizzo, Jr. (the “Executive”).
TRANSITION AND SUCCESSION AGREEMENTTransition and Succession Agreement • August 3rd, 2009 • Mylan Inc. • Pharmaceutical preparations • Pennsylvania
THIS TRANSITION AND SUCCESSION AGREEMENT (this “Agreement”) is entered into on June 1, 2009, effective as of June 8, 2009 (the “Commencement Date”), by and between Mylan Inc., a Pennsylvania corporation (the “Company”), and Jolene Varney (the “Executive”).
TRANSITION AND SUCCESSION AGREEMENTTransition and Succession Agreement • May 12th, 2008 • Mylan Inc. • Pharmaceutical preparations • Pennsylvania
THIS TRANSITION AND SUCCESSION AGREEMENT (this “Agreement”) is entered into as of this 31st day of January, 2007 (this “Agreement”), by and between Mylan Laboratories Inc., a Pennsylvania corporation (the “Company”), and Rajiv Malik (the “Executive”).
TRANSITION AND SUCCESSION AGREEMENTTransition and Succession Agreement • May 30th, 2007 • Mylan Laboratories Inc • Pharmaceutical preparations • Pennsylvania
THIS TRANSITION AND SUCCESSION AGREEMENT (this “Agreement”) is entered into as of this 31st day of January, 2007 (this “Agreement”), by and between Mylan Laboratories Inc., a Pennsylvania corporation (the “Company”), and Rajiv Malik (the “Executive”).
TRANSITION AND SUCCESSION AGREEMENTTransition and Succession Agreement • January 10th, 2007 • Mylan Laboratories Inc • Pharmaceutical preparations • Pennsylvania
THIS TRANSITION AND SUCCESSION AGREEMENT (this “Agreement”) is entered into as of this 8th day of January, 2007 (this “Agreement”), by and between Mylan Laboratories Inc., a Pennsylvania corporation (the “Company”), and Prasad Nimmagadda (the “Executive”).
AMENDED AND RESTATED TRANSITION AND SUCCESSION AGREEMENTTransition and Succession Agreement • May 16th, 2006 • Mylan Laboratories Inc • Pharmaceutical preparations • Pennsylvania
AMENDED AND RESTATED TRANSITION AND SUCCESSION AGREEMENT, dated as of the 3rd day of April, 2006 (this “Agreement”), by and between Mylan Laboratories Inc., a Pennsylvania corporation (the “Company”), and Stuart A. Williams (the “Executive”).
TRANSITION AND SUCCESSION AGREEMENTTransition and Succession Agreement • February 6th, 2004 • Mylan Laboratories Inc • Pharmaceutical preparations • Pennsylvania
AGREEMENT, dated as of the 15th day of December, 2003 (this “Agreement”), by and between Mylan Laboratories Inc., a Pennsylvania corporation (the “Company”), and Louis J. DeBone (the “Executive”).
TRANSITION AND SUCCESSION AGREEMENTTransition and Succession Agreement • February 6th, 2004 • Mylan Laboratories Inc • Pharmaceutical preparations • Pennsylvania
AGREEMENT, dated as of the 15th day of December, 2003 (this “Agreement”), by and between Mylan Laboratories Inc., a Pennsylvania corporation (the “Company”), and John P. O’Donnell (the “Executive”).
TRANSITION AND SUCCESSION AGREEMENTTransition and Succession Agreement • February 6th, 2004 • Mylan Laboratories Inc • Pharmaceutical preparations • Pennsylvania
AGREEMENT, dated as of the 15th day of December, 2003 (this “Agreement”), by and between Mylan Laboratories Inc., a Pennsylvania corporation (the “Company”), and Edward J. Borkowski (the “Executive”).
TRANSITION AND SUCCESSION AGREEMENTTransition and Succession Agreement • February 6th, 2004 • Mylan Laboratories Inc • Pharmaceutical preparations • Pennsylvania
This Transition and Succession Agreement (this “Agreement”) is dated as of December 15, 2003, by and between Mylan Laboratories Inc., a Pennsylvania corporation (the “Company”), and (“Executive”).
